Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity

Mostrar otras versiones (1)

The COVID-19 pandemic caused by the coronavirus SARS-CoV-2 is a major global public threat. Currently, a worldwide effort has been mounted to generate billions of effective SARS-CoV-2 vaccine doses to immunize the world’s population at record speeds. However, there is still a demand for alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaglione, Antonella, Opp, Silvana, Hurtado, Alicia, Lin, Ziyan, Pampeno, Christine, Noval, Maria G., Thannickal, Sara A., Stapleford, Kenneth A., Meruelo, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359677/
https://www.ncbi.nlm.nih.gov/pubmed/34394127
http://dx.doi.org/10.3389/fimmu.2021.719077

Ejemplares similares

Ejemplares similares